These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30463589)

  • 21. Does enhanced environmental cleaning reduce carbapenem-resistant Acinetobacter baumannii colonization in the intensive care unit?
    Seok H; Jeon JH; Jung JH; Ahn SH; Seo M; Cho HK; Sung SA; Kim SH; Choi HK; Choi WS; Park DW
    Int J Infect Dis; 2021 Aug; 109():72-76. PubMed ID: 34229090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
    Ogutlu A; Guclu E; Karabay O; Utku AC; Tuna N; Yahyaoglu M
    Ann Clin Microbiol Antimicrob; 2014 Jan; 13():7. PubMed ID: 24405720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prompt control of an imported carbapenem-resistant Acinetobacter baumanii outbreak in a French intensive care unit].
    Guth C; Cavalli Z; Pernod C; Lhopital C; Wey P; Gerome P; Turc J
    Med Sante Trop; 2016; 26(1):110-2. PubMed ID: 27046931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eradication of multi-drug resistant Acinetobacter from an intensive care unit.
    Podnos YD; Cinat ME; Wilson SE; Cooke J; Gornick W; Thrupp LD
    Surg Infect (Larchmt); 2001; 2(4):297-301. PubMed ID: 12593705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach.
    Molter G; Seifert H; Mandraka F; Kasper G; Weidmann B; Hornei B; Öhler M; Schwimmbeck P; Kröschel P; Higgins PG; Reuter S
    J Hosp Infect; 2016 Feb; 92(2):194-8. PubMed ID: 26778130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensively drug-resistant Acinetobacter baumannii carrying bla
    Rodríguez-Lucas C; Rodicio MR; Vázquez X; Escudero D; Quindós B; Alaguero M; Fernández J
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):385-389. PubMed ID: 32808109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multimodal intervention program to control a long-term
    Valencia-Martín R; Gonzalez-Galan V; Alvarez-Marín R; Cazalla-Foncueva AM; Aldabó T; Gil-Navarro MV; Alonso-Araujo I; Martin C; Gordon R; García-Nuñez EJ; Perez R; Peñalva G; Aznar J; Conde M; Cisneros JM;
    Antimicrob Resist Infect Control; 2019; 8():199. PubMed ID: 31827780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and infection in 3 intensive care units in a Thai tertiary care center: a 3-year study.
    Apisarnthanarak A; Pinitchai U; Thongphubeth K; Yuekyen C; Warren DK; Fraser VJ;
    Clin Infect Dis; 2008 Sep; 47(6):760-7. PubMed ID: 18684100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intervention to reduce carbapenem-resistant
    Thatrimontrichai A; Pannaraj PS; Janjindamai W; Dissaneevate S; Maneenil G; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):710-715. PubMed ID: 32131902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
    Kousouli E; Zarkotou O; Politi L; Polimeri K; Vrioni G; Themeli-Digalaki K; Tsakris A; Pournaras S
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):43-50. PubMed ID: 28879405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
    Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
    Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital.
    Valencia R; Arroyo LA; Conde M; Aldana JM; Torres MJ; Fernández-Cuenca F; Garnacho-Montero J; Cisneros JM; Ortíz C; Pachón J; Aznar J
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):257-63. PubMed ID: 19199531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
    Cheon S; Kim MJ; Yun SJ; Moon JY; Kim YS
    Korean J Intern Med; 2016 Mar; 31(2):367-74. PubMed ID: 26874513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.
    Thoma R; Seneghini M; Seiffert SN; Vuichard Gysin D; Scanferla G; Haller S; Flury D; Boggian K; Kleger GR; Filipovic M; Nolte O; Schlegel M; Kohler P
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):12. PubMed ID: 35063032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
    Markogiannakis A; Fildisis G; Tsiplakou S; Ikonomidis A; Koutsoukou A; Pournaras S; Manolis EN; Baltopoulos G; Tsakris A
    Infect Control Hosp Epidemiol; 2008 May; 29(5):410-7. PubMed ID: 18419362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factor for intestinal carriage of carbapenem-resistant
    Qiao F; Huang W; Gao S; Cai L; Zhu S; Wei L; Kang Y; Tao C; Zong Z
    BMJ Open; 2020 Sep; 10(9):e035893. PubMed ID: 32912943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the Impact of Antibiotic Exposures as Time-Dependent Variables on the Acquisition of Carbapenem-Resistant Acinetobacter baumannii.
    Munoz-Price LS; Rosa R; Castro JG; Laowansiri P; Latibeaudiere R; Namias N; Tarima S
    Crit Care Med; 2016 Oct; 44(10):e949-56. PubMed ID: 27167999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
    Aydemir H; Celebi G; Piskin N; Oztoprak N; Keskin AS; Aktas E; Sumbuloglu V; Akduman D
    Jpn J Infect Dis; 2012; 65(1):66-71. PubMed ID: 22274161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii.
    Chusri S; Singkhamanan K; Wanitsuwan W; Suphasynth Y; Kositpantawong N; Panthuwong S; Doi Y
    J Infect Chemother; 2019 Sep; 25(9):681-686. PubMed ID: 31003954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.